▶ 調査レポート

オリゴヌクレオチドの世界市場2020年:企業別、地域別、種類・用途別

• 英文タイトル:Global Oligonucleotides Market 2020 by Company, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。オリゴヌクレオチドの世界市場2020年:企業別、地域別、種類・用途別 / Global Oligonucleotides Market 2020 by Company, Regions, Type and Application, Forecast to 2025 / MRC2012B0905資料のイメージです。• レポートコード:MRC2012B0905
• 出版社/出版日:GlobalInfoResearch / 2020年12月24日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、124ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医薬品、医療
• 販売価格(消費税別)
  Single User¥522,000 (USD3,480)▷ お問い合わせ
  Multi User¥783,000 (USD5,220)▷ お問い合わせ
  Corporate User¥1,044,000 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、オリゴヌクレオチドの世界市場を広く調査・分析し、今後の市場展望をまとめております。オリゴヌクレオチドの種類別市場規模(DNAオリゴ、RNAオリゴ)、用途別市場規模(製薬、研究、診断)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。
・市場概要
・企業情報(販売量、市場シェア、製品概要、SWOT分析):Integrated DNA Technologies、GenScript、Eurofins Genomics、Agilent、Nitto Denko Avecia Inc、Sigma-aldrich、GeneDesign、Eurogentec S.A、L.G.C Biosearch Technologies、BBI Life Sciences、Creative Biogene、TriLink BioTechnologies、General Biosystems、Twist Bioscience、SGS DNA、LC Sciences、
・地域別グローバル市場分析 2015年-2020年
・オリゴヌクレオチドの北米市場(アメリカ、カナダ、メキシコ)
・オリゴヌクレオチドのヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・オリゴヌクレオチドのアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・オリゴヌクレオチドの南米市場(ブラジル、アルゼンチン)
・オリゴヌクレオチドの中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:DNAオリゴ、RNAオリゴ
・用途別分析:製薬、研究、診断
・地域別市場規模予測 2021年-2025年
・調査の結果・結論

Market Overview
The Oligonucleotides market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global Oligonucleotides market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 9.7%% in the forecast period of 2020 to 2025 and will expected to reach USD 1515 million by 2025, from USD 1047.5 million in 2019.

Market segmentation
Oligonucleotides market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Oligonucleotides market has been segmented into:
DNA Oligos
RNA Oligos

By Application, Oligonucleotides has been segmented into:
Pharmaceutical
Research
Diagnostic

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Oligonucleotides market presented in the report. This section sheds light on the sales growth of different regional and country-level Oligonucleotides markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Oligonucleotides market.

The report offers in-depth assessment of the growth and other aspects of the Oligonucleotides market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Oligonucleotides Market Share Analysis
Oligonucleotides competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Oligonucleotides sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Oligonucleotides sales, revenue and market share for each player covered in this report.

The major players covered in Oligonucleotides are:
Integrated DNA Technologies
GenScript
Eurofins Genomics
Agilent
Nitto Denko Avecia Inc
Sigma-aldrich
GeneDesign
Eurogentec S.A
L.G.C Biosearch Technologies
BBI Life Sciences
Creative Biogene
TriLink BioTechnologies
General Biosystems
Twist Bioscience
SGS DNA
LC Sciences
Among other players domestic and global, Oligonucleotides market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

レポート目次

1 Oligonucleotides Market Overview
1.1 Product Overview and Scope of Oligonucleotides
1.2 Classification of Oligonucleotides by Type
1.2.1 Global Oligonucleotides Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Oligonucleotides Revenue Market Share by Type in 2019
1.2.3 DNA Oligos
1.2.4 RNA Oligos
1.3 Global Oligonucleotides Market by Application
1.3.1 Overview: Global Oligonucleotides Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Pharmaceutical
1.3.3 Research
1.3.4 Diagnostic
1.4 Global Oligonucleotides Market by Regions
1.4.1 Global Oligonucleotides Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Oligonucleotides (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Oligonucleotides Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Oligonucleotides Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Oligonucleotides Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Oligonucleotides Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Oligonucleotides Status and Prospect (2015-2025)
2 Company Profiles
2.1 Integrated DNA Technologies
2.1.1 Integrated DNA Technologies Details
2.1.2 Integrated DNA Technologies Major Business
2.1.3 Integrated DNA Technologies SWOT Analysis
2.1.4 Integrated DNA Technologies Product and Services
2.1.5 Integrated DNA Technologies Oligonucleotides Revenue, Gross Margin and Market Share (2018-2019)
2.2 GenScript
2.2.1 GenScript Details
2.2.2 GenScript Major Business
2.2.3 GenScript SWOT Analysis
2.2.4 GenScript Product and Services
2.2.5 GenScript Oligonucleotides Revenue, Gross Margin and Market Share (2018-2019)
2.3 Eurofins Genomics
2.3.1 Eurofins Genomics Details
2.3.2 Eurofins Genomics Major Business
2.3.3 Eurofins Genomics SWOT Analysis
2.3.4 Eurofins Genomics Product and Services
2.3.5 Eurofins Genomics Oligonucleotides Revenue, Gross Margin and Market Share (2018-2019)
2.4 Agilent
2.4.1 Agilent Details
2.4.2 Agilent Major Business
2.4.3 Agilent SWOT Analysis
2.4.4 Agilent Product and Services
2.4.5 Agilent Oligonucleotides Revenue, Gross Margin and Market Share (2018-2019)
2.5 Nitto Denko Avecia Inc
2.5.1 Nitto Denko Avecia Inc Details
2.5.2 Nitto Denko Avecia Inc Major Business
2.5.3 Nitto Denko Avecia Inc SWOT Analysis
2.5.4 Nitto Denko Avecia Inc Product and Services
2.5.5 Nitto Denko Avecia Inc Oligonucleotides Revenue, Gross Margin and Market Share (2018-2019)
2.6 Sigma-aldrich
2.6.1 Sigma-aldrich Details
2.6.2 Sigma-aldrich Major Business
2.6.3 Sigma-aldrich Product and Services
2.6.4 Sigma-aldrich Oligonucleotides Revenue, Gross Margin and Market Share (2018-2019)
2.7 GeneDesign
2.7.1 GeneDesign Details
2.7.2 GeneDesign Major Business
2.7.3 GeneDesign Product and Services
2.7.4 GeneDesign Oligonucleotides Revenue, Gross Margin and Market Share (2018-2019)
2.8 Eurogentec S.A
2.8.1 Eurogentec S.A Details
2.8.2 Eurogentec S.A Major Business
2.8.3 Eurogentec S.A Product and Services
2.8.4 Eurogentec S.A Oligonucleotides Revenue, Gross Margin and Market Share (2018-2019)
2.9 L.G.C Biosearch Technologies
2.9.1 L.G.C Biosearch Technologies Details
2.9.2 L.G.C Biosearch Technologies Major Business
2.9.3 L.G.C Biosearch Technologies Product and Services
2.9.4 L.G.C Biosearch Technologies Oligonucleotides Revenue, Gross Margin and Market Share (2018-2019)
2.10 BBI Life Sciences
2.10.1 BBI Life Sciences Details
2.10.2 BBI Life Sciences Major Business
2.10.3 BBI Life Sciences Product and Services
2.10.4 BBI Life Sciences Oligonucleotides Revenue, Gross Margin and Market Share (2018-2019)
2.11 Creative Biogene
2.11.1 Creative Biogene Details
2.11.2 Creative Biogene Major Business
2.11.3 Creative Biogene Product and Services
2.11.4 Creative Biogene Oligonucleotides Revenue, Gross Margin and Market Share (2018-2019)
2.12 TriLink BioTechnologies
2.12.1 TriLink BioTechnologies Details
2.12.2 TriLink BioTechnologies Major Business
2.12.3 TriLink BioTechnologies Product and Services
2.12.4 TriLink BioTechnologies Oligonucleotides Revenue, Gross Margin and Market Share (2018-2019)
2.13 General Biosystems
2.13.1 General Biosystems Details
2.13.2 General Biosystems Major Business
2.13.3 General Biosystems Product and Services
2.13.4 General Biosystems Oligonucleotides Revenue, Gross Margin and Market Share (2018-2019)
2.14 Twist Bioscience
2.14.1 Twist Bioscience Details
2.14.2 Twist Bioscience Major Business
2.14.3 Twist Bioscience Product and Services
2.14.4 Twist Bioscience Oligonucleotides Revenue, Gross Margin and Market Share (2018-2019)
2.15 SGS DNA
2.15.1 SGS DNA Details
2.15.2 SGS DNA Major Business
2.15.3 SGS DNA Product and Services
2.15.4 SGS DNA Oligonucleotides Revenue, Gross Margin and Market Share (2018-2019)
2.16 LC Sciences
2.16.1 LC Sciences Details
2.16.2 LC Sciences Major Business
2.16.3 LC Sciences Product and Services
2.16.4 LC Sciences Oligonucleotides Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Oligonucleotides Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Oligonucleotides Players Market Share
3.2.2 Top 10 Oligonucleotides Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Oligonucleotides Revenue and Market Share by Regions
4.2 North America Oligonucleotides Revenue and Growth Rate (2015-2020)
4.3 Europe Oligonucleotides Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Oligonucleotides Revenue and Growth Rate (2015-2020)
4.5 South America Oligonucleotides Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Oligonucleotides Revenue and Growth Rate (2015-2020)
5 North America Oligonucleotides Revenue by Countries
5.1 North America Oligonucleotides Revenue by Countries (2015-2020)
5.2 USA Oligonucleotides Revenue and Growth Rate (2015-2020)
5.3 Canada Oligonucleotides Revenue and Growth Rate (2015-2020)
5.4 Mexico Oligonucleotides Revenue and Growth Rate (2015-2020)
6 Europe Oligonucleotides Revenue by Countries
6.1 Europe Oligonucleotides Revenue by Countries (2015-2020)
6.2 Germany Oligonucleotides Revenue and Growth Rate (2015-2020)
6.3 UK Oligonucleotides Revenue and Growth Rate (2015-2020)
6.4 France Oligonucleotides Revenue and Growth Rate (2015-2020)
6.5 Russia Oligonucleotides Revenue and Growth Rate (2015-2020)
6.6 Italy Oligonucleotides Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Oligonucleotides Revenue by Countries
7.1 Asia-Pacific Oligonucleotides Revenue by Countries (2015-2020)
7.2 China Oligonucleotides Revenue and Growth Rate (2015-2020)
7.3 Japan Oligonucleotides Revenue and Growth Rate (2015-2020)
7.4 Korea Oligonucleotides Revenue and Growth Rate (2015-2020)
7.5 India Oligonucleotides Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Oligonucleotides Revenue and Growth Rate (2015-2020)
8 South America Oligonucleotides Revenue by Countries
8.1 South America Oligonucleotides Revenue by Countries (2015-2020)
8.2 Brazil Oligonucleotides Revenue and Growth Rate (2015-2020)
8.3 Argentina Oligonucleotides Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Oligonucleotides by Countries
9.1 Middle East & Africa Oligonucleotides Revenue by Countries (2015-2020)
9.2 Saudi Arabia Oligonucleotides Revenue and Growth Rate (2015-2020)
9.3 UAE Oligonucleotides Revenue and Growth Rate (2015-2020)
9.4 Egypt Oligonucleotides Revenue and Growth Rate (2015-2020)
9.5 South Africa Oligonucleotides Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Oligonucleotides Revenue and Market Share by Type (2015-2020)
10.2 Global Oligonucleotides Market Forecast by Type (2019-2024)
10.3 DNA Oligos Revenue Growth Rate (2015-2025)
10.4 RNA Oligos Revenue Growth Rate (2015-2025)
11 Global Oligonucleotides Market Segment by Application
11.1 Global Oligonucleotides Revenue Market Share by Application (2015-2020)
11.2 Oligonucleotides Market Forecast by Application (2019-2024)
11.3 Pharmaceutical Revenue Growth (2015-2020)
11.4 Research Revenue Growth (2015-2020)
11.5 Diagnostic Revenue Growth (2015-2020)
12 Global Oligonucleotides Market Size Forecast (2021-2025)
12.1 Global Oligonucleotides Market Size Forecast (2021-2025)
12.2 Global Oligonucleotides Market Forecast by Regions (2021-2025)
12.3 North America Oligonucleotides Revenue Market Forecast (2021-2025)
12.4 Europe Oligonucleotides Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Oligonucleotides Revenue Market Forecast (2021-2025)
12.6 South America Oligonucleotides Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Oligonucleotides Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global Oligonucleotides Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Oligonucleotides by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Oligonucleotides Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Oligonucleotides Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Oligonucleotides Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Integrated DNA Technologies Corporate Information, Location and Competitors
Table 7. Integrated DNA Technologies Oligonucleotides Major Business
Table 8. Integrated DNA Technologies Oligonucleotides Total Revenue (USD Million) (2017-2018)
Table 9. Integrated DNA Technologies SWOT Analysis
Table 10. Integrated DNA Technologies Oligonucleotides Product and Solutions
Table 11. Integrated DNA Technologies Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. GenScript Corporate Information, Location and Competitors
Table 13. GenScript Oligonucleotides Major Business
Table 14. GenScript Oligonucleotides Total Revenue (USD Million) (2018-2019)
Table 15. GenScript SWOT Analysis
Table 16. GenScript Oligonucleotides Product and Solutions
Table 17. GenScript Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Eurofins Genomics Corporate Information, Location and Competitors
Table 19. Eurofins Genomics Oligonucleotides Major Business
Table 20. Eurofins Genomics Oligonucleotides Total Revenue (USD Million) (2017-2018)
Table 21. Eurofins Genomics SWOT Analysis
Table 22. Eurofins Genomics Oligonucleotides Product and Solutions
Table 23. Eurofins Genomics Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Agilent Corporate Information, Location and Competitors
Table 25. Agilent Oligonucleotides Major Business
Table 26. Agilent Oligonucleotides Total Revenue (USD Million) (2017-2018)
Table 27. Agilent SWOT Analysis
Table 28. Agilent Oligonucleotides Product and Solutions
Table 29. Agilent Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Nitto Denko Avecia Inc Corporate Information, Location and Competitors
Table 31. Nitto Denko Avecia Inc Oligonucleotides Major Business
Table 32. Nitto Denko Avecia Inc Oligonucleotides Total Revenue (USD Million) (2017-2018)
Table 33. Nitto Denko Avecia Inc SWOT Analysis
Table 34. Nitto Denko Avecia Inc Oligonucleotides Product and Solutions
Table 35. Nitto Denko Avecia Inc Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Sigma-aldrich Corporate Information, Location and Competitors
Table 37. Sigma-aldrich Oligonucleotides Major Business
Table 38. Sigma-aldrich Oligonucleotides Total Revenue (USD Million) (2017-2018)
Table 39. Sigma-aldrich SWOT Analysis
Table 40. Sigma-aldrich Oligonucleotides Product and Solutions
Table 41. Sigma-aldrich Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. GeneDesign Corporate Information, Location and Competitors
Table 43. GeneDesign Oligonucleotides Major Business
Table 44. GeneDesign Oligonucleotides Total Revenue (USD Million) (2017-2018)
Table 45. GeneDesign SWOT Analysis
Table 46. GeneDesign Oligonucleotides Product and Solutions
Table 47. GeneDesign Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Eurogentec S.A Corporate Information, Location and Competitors
Table 49. Eurogentec S.A Oligonucleotides Major Business
Table 50. Eurogentec S.A Oligonucleotides Total Revenue (USD Million) (2017-2018)
Table 51. Eurogentec S.A SWOT Analysis
Table 52. Eurogentec S.A Oligonucleotides Product and Solutions
Table 53. Eurogentec S.A Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. L.G.C Biosearch Technologies Corporate Information, Location and Competitors
Table 55. L.G.C Biosearch Technologies Oligonucleotides Major Business
Table 56. L.G.C Biosearch Technologies Oligonucleotides Total Revenue (USD Million) (2017-2018)
Table 57. L.G.C Biosearch Technologies SWOT Analysis
Table 58. L.G.C Biosearch Technologies Oligonucleotides Product and Solutions
Table 59. L.G.C Biosearch Technologies Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. BBI Life Sciences Corporate Information, Location and Competitors
Table 61. BBI Life Sciences Oligonucleotides Major Business
Table 62. BBI Life Sciences Oligonucleotides Total Revenue (USD Million) (2017-2018)
Table 63. BBI Life Sciences SWOT Analysis
Table 64. BBI Life Sciences Oligonucleotides Product and Solutions
Table 65. BBI Life Sciences Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Creative Biogene Corporate Information, Location and Competitors
Table 67. Creative Biogene Oligonucleotides Major Business
Table 68. Creative Biogene Oligonucleotides Total Revenue (USD Million) (2017-2018)
Table 69. Creative Biogene SWOT Analysis
Table 70. Creative Biogene Oligonucleotides Product and Solutions
Table 71. Creative Biogene Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. TriLink BioTechnologies Corporate Information, Location and Competitors
Table 73. TriLink BioTechnologies Oligonucleotides Major Business
Table 74. TriLink BioTechnologies Oligonucleotides Total Revenue (USD Million) (2017-2018)
Table 75. TriLink BioTechnologies SWOT Analysis
Table 76. TriLink BioTechnologies Oligonucleotides Product and Solutions
Table 77. TriLink BioTechnologies Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. General Biosystems Corporate Information, Location and Competitors
Table 79. General Biosystems Oligonucleotides Major Business
Table 80. General Biosystems Oligonucleotides Total Revenue (USD Million) (2017-2018)
Table 81. General Biosystems SWOT Analysis
Table 82. General Biosystems Oligonucleotides Product and Solutions
Table 83. General Biosystems Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 84. Twist Bioscience Corporate Information, Location and Competitors
Table 85. Twist Bioscience Oligonucleotides Major Business
Table 86. Twist Bioscience Oligonucleotides Total Revenue (USD Million) (2017-2018)
Table 87. Twist Bioscience SWOT Analysis
Table 88. Twist Bioscience Oligonucleotides Product and Solutions
Table 89. Twist Bioscience Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 90. SGS DNA Corporate Information, Location and Competitors
Table 91. SGS DNA Oligonucleotides Major Business
Table 92. SGS DNA Oligonucleotides Total Revenue (USD Million) (2017-2018)
Table 93. SGS DNA SWOT Analysis
Table 94. SGS DNA Oligonucleotides Product and Solutions
Table 95. SGS DNA Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 96. LC Sciences Corporate Information, Location and Competitors
Table 97. LC Sciences Oligonucleotides Major Business
Table 98. LC Sciences Oligonucleotides Total Revenue (USD Million) (2017-2018)
Table 99. LC Sciences SWOT Analysis
Table 100. LC Sciences Oligonucleotides Product and Solutions
Table 101. LC Sciences Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 102. Global Oligonucleotides Revenue (Million USD) by Players (2015-2020)
Table 103. Global Oligonucleotides Revenue Share by Players (2015-2020)
Table 104. Global Oligonucleotides Revenue (Million USD) by Regions (2015-2020)
Table 105. Global Oligonucleotides Revenue Market Share by Regions (2015-2020)
Table 106. North America Oligonucleotides Revenue by Countries (2015-2020)
Table 107. North America Oligonucleotides Revenue Market Share by Countries (2015-2020)
Table 108. Europe Oligonucleotides Revenue (Million USD) by Countries (2015-2020)
Table 109. Asia-Pacific Oligonucleotides Revenue (Million USD) by Countries (2015-2020)
Table 110. South America Oligonucleotides Revenue by Countries (2015-2020)
Table 111. South America Oligonucleotides Revenue Market Share by Countries (2015-2020)
Table 112. Middle East and Africa Oligonucleotides Revenue (Million USD) by Countries (2015-2020)
Table 113. Middle East and Africa Oligonucleotides Revenue Market Share by Countries (2015-2020)
Table 114. Global Oligonucleotides Revenue (Million USD) by Type (2015-2020)
Table 115. Global Oligonucleotides Revenue Share by Type (2015-2020)
Table 116. Global Oligonucleotides Revenue Forecast by Type (2021-2025)
Table 117. Global Oligonucleotides Revenue by Application (2015-2020)
Table 118. Global Oligonucleotides Revenue Share by Application (2015-2020)
Table 119. Global Oligonucleotides Revenue Forecast by Application (2021-2025)
Table 120. Global Oligonucleotides Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Oligonucleotides Picture
Figure 2. Global Oligonucleotides Revenue Market Share by Type in 2019
Figure 3. DNA Oligos Picture
Figure 4. RNA Oligos Picture
Figure 5. Oligonucleotides Revenue Market Share by Application in 2019
Figure 6. Pharmaceutical Picture
Figure 7. Research Picture
Figure 8. Diagnostic Picture
Figure 9. Global Oligonucleotides Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Oligonucleotides Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Oligonucleotides Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Oligonucleotides Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Oligonucleotides Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Oligonucleotides Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Oligonucleotides Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Oligonucleotides Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Oligonucleotides Revenue Market Share in 2019
Figure 18. Global Top 10 Players Oligonucleotides Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Oligonucleotides Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Oligonucleotides Revenue Market Share by Regions (2015-2020)
Figure 22. Global Oligonucleotides Revenue Market Share by Regions in 2018
Figure 23. North America Oligonucleotides Revenue and Growth Rate (2015-2020)
Figure 24. Europe Oligonucleotides Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Oligonucleotides Revenue and Growth Rate (2015-2020)
Figure 26. South America Oligonucleotides Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Oligonucleotides Revenue and Growth Rate (2015-2020)
Figure 28. North America Oligonucleotides Revenue Market Share by Countries (2015-2020)
Figure 29. North America Oligonucleotides Revenue Market Share by Countries in 2019
Figure 30. USA Oligonucleotides Revenue and Growth Rate (2015-2020)
Figure 31. Canada Oligonucleotides Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Oligonucleotides Revenue and Growth Rate (2015-2020)
Figure 33. Europe Oligonucleotides Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Oligonucleotides Revenue Market Share by Countries in 2019
Figure 35. Germany Oligonucleotides Revenue and Growth Rate (2015-2020)
Figure 36. UK Oligonucleotides Revenue and Growth Rate (2015-2020)
Figure 37. France Oligonucleotides Revenue and Growth Rate (2015-2020)
Figure 38. Russia Oligonucleotides Revenue and Growth Rate (2015-2020)
Figure 39. Italy Oligonucleotides Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Oligonucleotides Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Oligonucleotides Revenue Market Share by Countries in 2019
Figure 42. China Oligonucleotides Revenue and Growth Rate (2015-2020)
Figure 43. Japan Oligonucleotides Revenue and Growth Rate (2015-2020)
Figure 44. Korea Oligonucleotides Revenue and Growth Rate (2015-2020)
Figure 45. India Oligonucleotides Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Oligonucleotides Revenue and Growth Rate (2015-2020)
Figure 47. South America Oligonucleotides Revenue Market Share by Countries (2015-2020)
Figure 48. South America Oligonucleotides Revenue Market Share by Countries in 2019
Figure 49. Brazil Oligonucleotides Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Oligonucleotides Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Oligonucleotides Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Oligonucleotides Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Oligonucleotides Revenue and Growth Rate (2015-2020)
Figure 54. UAE Oligonucleotides Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Oligonucleotides Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Oligonucleotides Revenue and Growth Rate (2015-2020)
Figure 57. Global Oligonucleotides Revenue Share by Type (2015-2020)
Figure 58. Global Oligonucleotides Revenue Share by Type in 2019
Figure 59. Global Oligonucleotides Market Share Forecast by Type (2021-2025)
Figure 60. Global DNA Oligos Revenue Growth Rate (2015-2020)
Figure 61. Global RNA Oligos Revenue Growth Rate (2015-2020)
Figure 62. Global Oligonucleotides Revenue Share by Application (2015-2020)
Figure 63. Global Oligonucleotides Revenue Share by Application in 2019
Figure 64. Global Oligonucleotides Market Share Forecast by Application (2021-2025)
Figure 65. Global Pharmaceutical Revenue Growth Rate (2015-2020)
Figure 66. Global Research Revenue Growth Rate (2015-2020)
Figure 67. Global Diagnostic Revenue Growth Rate (2015-2020)
Figure 68. Global Oligonucleotides Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Oligonucleotides Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Oligonucleotides Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Oligonucleotides Revenue Market Forecast (2021-2025)
Figure 72. Europe Oligonucleotides Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Oligonucleotides Revenue Market Forecast (2021-2025)
Figure 74. South America Oligonucleotides Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Oligonucleotides Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel